rs10776910
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000093.5(COL5A1):c.4176+35A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.42 in 1,593,238 control chromosomes in the GnomAD database, including 143,903 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.47 ( 17317 hom., cov: 33)
Exomes 𝑓: 0.42 ( 126586 hom. )
Consequence
COL5A1
NM_000093.5 intron
NM_000093.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.10
Publications
9 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 9-134817114-A-C is Benign according to our data. Variant chr9-134817114-A-C is described in ClinVar as Benign. ClinVar VariationId is 255085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.616 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.4176+35A>C | intron_variant | Intron 53 of 65 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.4176+35A>C | intron_variant | Intron 53 of 65 | NP_001265003.1 | |||
| COL5A1 | XM_017014266.3 | c.4176+35A>C | intron_variant | Intron 53 of 64 | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.466 AC: 70830AN: 151884Hom.: 17291 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
70830
AN:
151884
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.414 AC: 103242AN: 249602 AF XY: 0.407 show subpopulations
GnomAD2 exomes
AF:
AC:
103242
AN:
249602
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.415 AC: 598688AN: 1441236Hom.: 126586 Cov.: 29 AF XY: 0.414 AC XY: 297030AN XY: 718112 show subpopulations
GnomAD4 exome
AF:
AC:
598688
AN:
1441236
Hom.:
Cov.:
29
AF XY:
AC XY:
297030
AN XY:
718112
show subpopulations
African (AFR)
AF:
AC:
20984
AN:
33236
American (AMR)
AF:
AC:
16674
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
AC:
9603
AN:
25976
East Asian (EAS)
AF:
AC:
17854
AN:
39558
South Asian (SAS)
AF:
AC:
30263
AN:
85852
European-Finnish (FIN)
AF:
AC:
19117
AN:
53114
Middle Eastern (MID)
AF:
AC:
2413
AN:
5488
European-Non Finnish (NFE)
AF:
AC:
456636
AN:
1093680
Other (OTH)
AF:
AC:
25144
AN:
59728
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
15312
30624
45936
61248
76560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13920
27840
41760
55680
69600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.466 AC: 70908AN: 152002Hom.: 17317 Cov.: 33 AF XY: 0.459 AC XY: 34124AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
70908
AN:
152002
Hom.:
Cov.:
33
AF XY:
AC XY:
34124
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
25780
AN:
41450
American (AMR)
AF:
AC:
6020
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1265
AN:
3464
East Asian (EAS)
AF:
AC:
2361
AN:
5154
South Asian (SAS)
AF:
AC:
1625
AN:
4818
European-Finnish (FIN)
AF:
AC:
3847
AN:
10564
Middle Eastern (MID)
AF:
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28566
AN:
67950
Other (OTH)
AF:
AC:
952
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1942
3883
5825
7766
9708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1400
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fibromuscular dysplasia, multifocal Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.